SEER vs. GANX

Last updated Apr 1, 2026

Compare and contrast key facts about Seer, Inc. (SEER) and Gain Therapeutics, Inc. (GANX).

Performance

SEER vs. GANX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Seer, Inc. (SEER) and Gain Therapeutics, Inc. (GANX). The values are adjusted to include any dividend payments, if applicable.

SEER vs. GANX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
SEER Seer, Inc.	-8.20%	-20.78%	19.07%	-66.55%	-74.57%	-53.07%
GANX Gain Therapeutics, Inc.	-39.75%	49.07%	-33.84%	4.31%	-42.36%	-51.52%

Fundamentals

Market Cap SEER : $96.51M GANX : $63.96M
EPS SEER : -$1.28 GANX : -$0.62
PB Ratio SEER : 0.37 GANX : 3.45
Total Revenue (TTM) SEER : $16.58M GANX : $0.00
Gross Profit (TTM) SEER : $8.47M GANX : -$4.97M
EBITDA (TTM) SEER : -$64.19M GANX : -$18.63M

Returns By Period

In the year-to-date period, SEER achieves a -8.20% return, which is significantly higher than GANX's -39.75% return.

SEER

• 1D: 0.00%
• 1M: -2.33%
• YTD: -8.20%
• 6M: -22.58%
• 1Y: -0.59%
• 3Y*: -24.22%
• 5Y*: -49.70%
• 10Y*: —

GANX

• 1D: 7.78%
• 1M: -25.67%
• YTD: -39.75%
• 6M: 9.60%
• 1Y: 1.57%
• 3Y*: -26.17%
• 5Y*: -33.92%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

SEER vs. GANX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SEER

SEER Risk / Return Rank: 38
SEER Sharpe Ratio Rank: 40
SEER Sortino Ratio Rank: 37
SEER Omega Ratio Rank: 37
SEER Calmar Ratio Rank: 37
SEER Martin Ratio Rank: 37

GANX

GANX Risk / Return Rank: 46
GANX Sharpe Ratio Rank: 41
GANX Sortino Ratio Rank: 52
GANX Omega Ratio Rank: 52
GANX Calmar Ratio Rank: 43
GANX Martin Ratio Rank: 42

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SEER vs. GANX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Seer, Inc. (SEER) and Gain Therapeutics, Inc. (GANX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SEER	GANX	Difference
Sharpe ratio Return per unit of total volatility	-0.01	0.01	-0.03
Sortino ratio Return per unit of downside risk	0.33	0.88	-0.55
Omega ratio Gain probability vs. loss probability	1.04	1.12	-0.08
Calmar ratio Return relative to maximum drawdown	-0.12	0.04	-0.16
Martin ratio Return relative to average drawdown	-0.24	0.09	-0.33
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SEER vs. GANX - Sharpe Ratio Comparison

The current SEER Sharpe Ratio is -0.01, which is lower than the GANX Sharpe Ratio of 0.01. The chart below compares the historical Sharpe Ratios of SEER and GANX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	SEER	GANX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.01	0.01	-0.03
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.66	-0.40	-0.27
Sharpe Ratio (All Time) Calculated using the full available price history	-0.62	-0.34	-0.28

Correlation

The correlation between SEER and GANX is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

SEER vs. GANX - Dividend Comparison

Neither SEER nor GANX has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

SEER vs. GANX - Drawdown Comparison

The maximum SEER drawdown since its inception was -98.25%, roughly equal to the maximum GANX drawdown of -94.08%. Use the drawdown chart below to compare losses from any high point for SEER and GANX.

Drawdown Indicators

	SEER	GANX	Difference
Max Drawdown Largest peak-to-trough decline	-98.25%	-94.08%	-4.17%
Max Drawdown (1Y) Largest decline over 1 year	-29.96%	-61.24%	+31.28%
Max Drawdown (5Y) Largest decline over 5 years	-97.42%	-94.08%	-3.34%
Current Drawdown Current decline from peak	-98.00%	-87.72%	-10.28%
Average Drawdown Average peak-to-trough decline	-85.80%	-75.00%	-10.80%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.50%	28.50%	-14.00%

Volatility

SEER vs. GANX - Volatility Comparison

The current volatility for Seer, Inc. (SEER) is 9.67%, while Gain Therapeutics, Inc. (GANX) has a volatility of 40.66%. This indicates that SEER experiences smaller price fluctuations and is considered to be less risky than GANX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SEER	GANX	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.67%	40.66%	-30.99%
Volatility (6M) Calculated over the trailing 6-month period	30.26%	102.19%	-71.93%
Volatility (1Y) Calculated over the trailing 1-year period	45.61%	110.47%	-64.86%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	75.03%	85.80%	-10.77%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	78.01%	85.89%	-7.88%

Financials